Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Transfusion-transmitted hepatitis C: A cluster of cases in transfusion-dependent thalassaemia patients in Sri Lanka.

Perera S, Bonsall D, Niriella MA, Allen A, Peries AC, Nelumdeniya UB, Dissanayake R, Silva I, de Cesare M, Klenerman P, Weatherall DJ, Roberts DJ, Premawardhena AP.

Transfus Med. 2020 Jan 8. doi: 10.1111/tme.12660. [Epub ahead of print]

PMID:
31916330
2.

Oxford Nanopore MinION Sequencing Enables Rapid Whole Genome Assembly of Rickettsia typhi in a Resource-Limited Setting.

Elliott I, Batty EM, Ming D, Robinson MT, Nawtaisong P, de Cesare M, Newton PN, Bowden R.

Am J Trop Med Hyg. 2020 Feb;102(2):408-414. doi: 10.4269/ajtmh.19-0383.

3.

Prolonged Zika Virus RNA Detection in Semen of Immunosuppressed Patient.

Petridou C, Bonsall D, Ahmed A, Roberts M, Bell C, de Cesare M, Bowden R, Graham V, Bailey D, Simpson A, Aarons E.

Emerg Infect Dis. 2019 Aug;25(8):1598-1600. doi: 10.3201/eid2508.181543.

4.

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV).

McNaughton AL, Roberts HE, Bonsall D, de Cesare M, Mokaya J, Lumley SF, Golubchik T, Piazza P, Martin JB, de Lara C, Brown A, Ansari MA, Bowden R, Barnes E, Matthews PC.

Sci Rep. 2019 May 8;9(1):7081. doi: 10.1038/s41598-019-43524-9.

5.

Sequencing of human genomes with nanopore technology.

Bowden R, Davies RW, Heger A, Pagnamenta AT, de Cesare M, Oikkonen LE, Parkes D, Freeman C, Dhalla F, Patel SY, Popitsch N, Ip CLC, Roberts HE, Salatino S, Lockstone H, Lunter G, Taylor JC, Buck D, Simpson MA, Donnelly P.

Nat Commun. 2019 Apr 23;10(1):1869. doi: 10.1038/s41467-019-09637-5.

6.

Efficacy of a Selective Binder of αVβ3 Integrin Linked to the Tyrosine Kinase Inhibitor Sunitinib in Ovarian Carcinoma Preclinical Models.

Sartori A, Corno C, De Cesare M, Scanziani E, Minoli L, Battistini L, Zanardi F, Perego P.

Cancers (Basel). 2019 Apr 13;11(4). pii: E531. doi: 10.3390/cancers11040531.

7.

Rapid tools to gain insights into the interaction dynamics of new 8-hydroxyquinolines with few fungal lines.

Joaquim AR, Pippi B, de Cesare MA, Rocha DA, Boff RT, Staudt KJ, Ruaro TC, Zimmer AR, de Araújo BV, Silveira GP, Martins AF, Teixeira ML, Dos Santos FP, Fuentefria AM, de Andrade SF.

Chem Biol Drug Des. 2019 Jun;93(6):1186-1196. doi: 10.1111/cbdd.13435. Epub 2018 Nov 19.

PMID:
30450782
8.

High Efficacy of Intravenous Gimatecan on Human Tumor Xenografts.

DE Cesare M.

Anticancer Res. 2018 Oct;38(10):5783-5790. doi: 10.21873/anticanres.12917.

PMID:
30275200
9.

Genomic Epidemiology Reconstructs the Introduction and Spread of Zika Virus in Central America and Mexico.

Thézé J, Li T, du Plessis L, Bouquet J, Kraemer MUG, Somasekar S, Yu G, de Cesare M, Balmaseda A, Kuan G, Harris E, Wu CH, Ansari MA, Bowden R, Faria NR, Yagi S, Messenger S, Brooks T, Stone M, Bloch EM, Busch M, Muñoz-Medina JE, González-Bonilla CR, Wolinsky S, López S, Arias CF, Bonsall D, Chiu CY, Pybus OG.

Cell Host Microbe. 2018 Jun 13;23(6):855-864.e7. doi: 10.1016/j.chom.2018.04.017. Epub 2018 May 24.

10.

Synthesis and Evaluation of the Tumor Cell Growth Inhibitory Potential of New Putative HSP90 Inhibitors.

Bizarro A, Sousa D, Lima RT, Musso L, Cincinelli R, Zuco V, De Cesare M, Dallavalle S, Vasconcelos MH.

Molecules. 2018 Feb 13;23(2). pii: E407. doi: 10.3390/molecules23020407.

11.

Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases.

Cassinelli G, Dal Bo L, Favini E, Cominetti D, Pozzi S, Tortoreto M, De Cesare M, Lecis D, Scanziani E, Minoli L, Naggi A, Vlodavsky I, Zaffaroni N, Lanzi C.

Cancer Lett. 2018 Feb 28;415:187-197. doi: 10.1016/j.canlet.2017.12.009. Epub 2017 Dec 7.

PMID:
29225052
12.

PHYLOSCANNER: Inferring Transmission from Within- and Between-Host Pathogen Genetic Diversity.

Wymant C, Hall M, Ratmann O, Bonsall D, Golubchik T, de Cesare M, Gall A, Cornelissen M, Fraser C; STOP-HCV Consortium, The Maela Pneumococcal Collaboration, and The BEEHIVE Collaboration.

Mol Biol Evol. 2018 Mar 1;35(3):719-733. doi: 10.1093/molbev/msx304.

13.

FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models.

Corno C, Stucchi S, De Cesare M, Carenini N, Stamatakos S, Ciusani E, Minoli L, Scanziani E, Argueta C, Landesman Y, Zaffaroni N, Gatti L, Perego P.

Biochem Pharmacol. 2018 Jan;147:93-103. doi: 10.1016/j.bcp.2017.11.009. Epub 2017 Nov 16.

PMID:
29155058
14.

Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysis.

Weirather JL, de Cesare M, Wang Y, Piazza P, Sebastiano V, Wang XJ, Buck D, Au KF.

Version 2. F1000Res. 2017 Feb 3 [revised 2017 Jan 1];6:100. doi: 10.12688/f1000research.10571.2. eCollection 2017.

15.

Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat.

Rossini A, Zunino F, Ruggiero G, De Cesare M, Cominetti D, Tortoreto M, Lanzi C, Cassinelli G, Zappasodi R, Tripodo C, Gulino A, Zaffaroni N, Di Nicola M.

Hematol Oncol. 2018 Feb;36(1):360-362. doi: 10.1002/hon.2466. Epub 2017 Jul 21. No abstract available.

PMID:
28730742
16.

Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline.

Sani M, Lazzari P, Folini M, Spiga M, Zuco V, De Cesare M, Manca I, Dall'Angelo S, Frigerio M, Usai I, Testa A, Zaffaroni N, Zanda M.

Chemistry. 2017 Apr 27;23(24):5842-5850. doi: 10.1002/chem.201700874. Epub 2017 Apr 12.

PMID:
28300330
17.

1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment.

Ferroni C, Pepe A, Kim YS, Lee S, Guerrini A, Parenti MD, Tesei A, Zamagni A, Cortesi M, Zaffaroni N, De Cesare M, Beretta GL, Trepel JB, Malhotra SV, Varchi G.

J Med Chem. 2017 Apr 13;60(7):3082-3093. doi: 10.1021/acs.jmedchem.7b00105. Epub 2017 Mar 20.

PMID:
28272894
18.

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.

El Bezawy R, De Cesare M, Pennati M, Deraco M, Gandellini P, Zuco V, Zaffaroni N.

J Hematol Oncol. 2017 Jan 18;10(1):19. doi: 10.1186/s13045-016-0387-6.

19.

Local conformal symmetry in non-Riemannian geometry and the origin of physical scales.

de Cesare M, Moffat JW, Sakellariadou M.

Eur Phys J C Part Fields. 2017;77(9):605. doi: 10.1140/epjc/s10052-017-5183-0. Epub 2017 Sep 14.

20.

A systematic review of passive exposure to cannabis.

Berthet A, De Cesare M, Favrat B, Sporkert F, Augsburger M, Thomas A, Giroud C.

Forensic Sci Int. 2016 Dec;269:97-112. doi: 10.1016/j.forsciint.2016.11.017. Epub 2016 Nov 16. Review.

21.

3-Arylidene-N-hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity.

Musso L, Cincinelli R, Zuco V, De Cesare M, Zunino F, Fallacara AL, Botta M, Dallavalle S.

ChemMedChem. 2016 Aug 19;11(16):1700-4. doi: 10.1002/cmdc.201600225. Epub 2016 Jun 17.

22.

Drug vaping applied to cannabis: Is "Cannavaping" a therapeutic alternative to marijuana?

Varlet V, Concha-Lozano N, Berthet A, Plateel G, Favrat B, De Cesare M, Lauer E, Augsburger M, Thomas A, Giroud C.

Sci Rep. 2016 May 26;6:25599. doi: 10.1038/srep25599.

23.

Corrigendum: Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TE, Crook DW, Iqbal Z.

Nat Commun. 2016 Apr 20;7:11465. doi: 10.1038/ncomms11465. No abstract available.

24.

Targeting peptidyl-prolyl isomerase pin1 to inhibit tumor cell aggressiveness.

Beretta GL, De Cesare M, Albano L, Magnifico A, Carenini N, Corna E, Perego P, Gatti L.

Tumori. 2016 Mar-Apr;102(2):144-9. doi: 10.5301/tj.5000471. Epub 2016 Feb 19.

PMID:
26917410
25.

Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity.

Cincinelli R, Zwick V, Musso L, Zuco V, De Cesare M, Zunino F, Simoes-Pires C, Nurisso A, Giannini G, Cuendet M, Dallavalle S.

Eur J Med Chem. 2016 Apr 13;112:99-105. doi: 10.1016/j.ejmech.2016.02.001. Epub 2016 Feb 3.

26.

MinION Analysis and Reference Consortium: Phase 1 data release and analysis.

Ip CLC, Loose M, Tyson JR, de Cesare M, Brown BL, Jain M, Leggett RM, Eccles DA, Zalunin V, Urban JM, Piazza P, Bowden RJ, Paten B, Mwaigwisya S, Batty EM, Simpson JT, Snutch TP, Birney E, Buck D, Goodwin S, Jansen HJ, O'Grady J, Olsen HE; MinION Analysis and Reference Consortium.

F1000Res. 2015 Oct 15;4:1075. doi: 10.12688/f1000research.7201.1. eCollection 2015.

27.

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts.

De Cesare M, Sfondrini L, Pennati M, De Marco C, Motta V, Tagliabue E, Deraco M, Balsari A, Zaffaroni N.

J Transl Med. 2016 Jan 25;14:25. doi: 10.1186/s12967-016-0781-4.

28.

Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Bradley P, Gordon NC, Walker TM, Dunn L, Heys S, Huang B, Earle S, Pankhurst LJ, Anson L, de Cesare M, Piazza P, Votintseva AA, Golubchik T, Wilson DJ, Wyllie DH, Diel R, Niemann S, Feuerriegel S, Kohl TA, Ismail N, Omar SV, Smith EG, Buck D, McVean G, Walker AS, Peto TE, Crook DW, Iqbal Z.

Nat Commun. 2015 Dec 21;6:10063. doi: 10.1038/ncomms10063. Erratum in: Nat Commun. 2016;7:11465.

29.

On the possibility of tree-level leptogenesis from Kalb-Ramond torsion background.

de Cesare M, Mavromatos NE, Sarkar S.

Eur Phys J C Part Fields. 2015;75(10):514. Epub 2015 Oct 29.

30.

E-Cigarettes: A Review of New Trends in Cannabis Use.

Giroud C, de Cesare M, Berthet A, Varlet V, Concha-Lozano N, Favrat B.

Int J Environ Res Public Health. 2015 Aug 21;12(8):9988-10008. doi: 10.3390/ijerph120809988. Review.

31.

(236)U and (239,)(240)Pu ratios from soils around an Australian nuclear weapons test site.

Tims SG, Froehlich MB, Fifield LK, Wallner A, De Cesare M.

J Environ Radioact. 2016 Jan;151 Pt 3:563-7. doi: 10.1016/j.jenvrad.2015.06.020. Epub 2015 Jul 2.

PMID:
26141189
32.

Uranium beam characterization at CIRCE for background and contamination determinations.

De Cesare M, De Cesare N, D'Onofrio A, Fifield LK, Gialanella L, Terrasi F.

Appl Radiat Isot. 2015 Sep;103:166-72. doi: 10.1016/j.apradiso.2015.06.011. Epub 2015 Jun 11.

PMID:
26103623
33.

Design, synthesis and biological evaluation of novel dimeric and tetrameric cRGD-paclitaxel conjugates for integrin-assisted drug delivery.

Bianchi A, Arosio D, Perego P, De Cesare M, Carenini N, Zaffaroni N, De Matteo M, Manzoni L.

Org Biomol Chem. 2015 Jul 21;13(27):7530-41. doi: 10.1039/c5ob00497g.

PMID:
26074454
34.

Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.

De Cesare M, Cominetti D, Doldi V, Lopergolo A, Deraco M, Gandellini P, Friedlander S, Landesman Y, Kauffman MG, Shacham S, Pennati M, Zaffaroni N.

Oncotarget. 2015 May 30;6(15):13119-32.

36.

Nuclear SSR markers for Miscanthus, Saccharum, and related grasses (Saccharinae, Poaceae).

Hodkinson TR, de Cesare M, Barth S.

Appl Plant Sci. 2013 Nov 7;1(11). pii: apps.1300042. doi: 10.3732/apps.1300042. eCollection 2013 Nov.

37.

A new avenue toward androgen receptor pan-antagonists: C2 sterically hindered substitution of hydroxy-propanamides.

Guerrini A, Tesei A, Ferroni C, Paganelli G, Zamagni A, Carloni S, Di Donato M, Castoria G, Leonetti C, Porru M, De Cesare M, Zaffaroni N, Beretta GL, Del Rio A, Varchi G.

J Med Chem. 2014 Sep 11;57(17):7263-79. doi: 10.1021/jm5005122. Epub 2014 Aug 28.

PMID:
25121586
38.

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.

Gatti L, Sevko A, De Cesare M, Arrighetti N, Manenti G, Ciusani E, Verderio P, Ciniselli CM, Cominetti D, Carenini N, Corna E, Zaffaroni N, Rodolfo M, Rivoltini L, Umansky V, Perego P.

Oncotarget. 2014 Jun 30;5(12):4516-28.

39.

YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.

Pennati M, Sbarra S, De Cesare M, Lopergolo A, Locatelli SL, Campi E, Daidone MG, Carlo-Stella C, Gianni AM, Zaffaroni N.

Int J Cancer. 2015 Jan 15;136(2):299-309. doi: 10.1002/ijc.28993. Epub 2014 Jun 5.

40.

Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors.

Cincinelli R, Musso L, Giannini G, Zuco V, De Cesare M, Zunino F, Dallavalle S.

Eur J Med Chem. 2014 May 22;79:251-9. doi: 10.1016/j.ejmech.2014.04.021. Epub 2014 Apr 8.

41.

First measurements of (236)U concentrations and (236)U/(239)Pu isotopic ratios in a Southern Hemisphere soil far from nuclear test or reactor sites.

Srncik M, Tims SG, De Cesare M, Fifield LK.

J Environ Radioact. 2014 Jun;132:108-14. doi: 10.1016/j.jenvrad.2014.02.022. Epub 2014 Mar 12.

PMID:
24631872
42.

miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells.

Pennati M, Lopergolo A, Profumo V, De Cesare M, Sbarra S, Valdagni R, Zaffaroni N, Gandellini P, Folini M.

Biochem Pharmacol. 2014 Feb 15;87(4):579-97. doi: 10.1016/j.bcp.2013.12.009. Epub 2013 Dec 24.

PMID:
24370341
43.

Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.

Gatti L, Cossa G, Tinelli S, Carenini N, Arrighetti N, Pennati M, Cominetti D, De Cesare M, Zunino F, Zaffaroni N, Perego P.

J Pharmacol Exp Ther. 2014 Mar;348(3):360-71. doi: 10.1124/jpet.113.210054. Epub 2013 Dec 17.

PMID:
24345465
44.

Synergistic antitumor activity of cetuximab and namitecan in human squamous cell carcinoma models relies on cooperative inhibition of EGFR expression and depends on high EGFR gene copy number.

De Cesare M, Lauricella C, Veronese SM, Cominetti D, Pisano C, Zunino F, Zaffaroni N, Zuco V.

Clin Cancer Res. 2014 Feb 15;20(4):995-1006. doi: 10.1158/1078-0432.CCR-13-1684. Epub 2013 Dec 10.

45.

Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma.

Gatti L, De Cesare M, Ciusani E, Corna E, Arrighetti N, Cominetti D, Belvisi L, Potenza D, Moroni E, Vasile F, Lecis D, Delia D, Castiglioni V, Scanziani E, Seneci P, Zaffaroni N, Perego P.

Mol Pharm. 2014 Jan 6;11(1):283-93. doi: 10.1021/mp4004578. Epub 2013 Nov 27.

PMID:
24256025
46.

Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity.

Lecis D, De Cesare M, Perego P, Conti A, Corna E, Drago C, Seneci P, Walczak H, Colombo MP, Delia D, Sangaletti S.

Cell Death Dis. 2013 Nov 14;4:e920. doi: 10.1038/cddis.2013.449.

47.

Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental models.

Carbone A, Pennati M, Parrino B, Lopergolo A, Barraja P, Montalbano A, Spanò V, Sbarra S, Doldi V, De Cesare M, Cirrincione G, Diana P, Zaffaroni N.

J Med Chem. 2013 Sep 12;56(17):7060-72. doi: 10.1021/jm400842x. Epub 2013 Aug 23.

PMID:
23919303
48.

Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agents.

Cincinelli R, Musso L, Dallavalle S, Artali R, Tinelli S, Colangelo D, Zunino F, De Cesare M, Beretta GL, Zaffaroni N.

Eur J Med Chem. 2013 May;63:387-400. doi: 10.1016/j.ejmech.2013.02.022. Epub 2013 Mar 1.

49.

High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors.

Sommariva M, de Cesare M, Meini A, Cataldo A, Zaffaroni N, Tagliabue E, Balsari A.

J Transl Med. 2013 Jan 29;11:25. doi: 10.1186/1479-5876-11-25.

50.

Virtual anthropology: a comparison between the performance of conventional X-ray and MDCT in investigating the trabecular structure of long bones.

de Froidmont S, Grabherr S, Vaucher P, De Cesare M, Egger C, Papageorgopoulou C, Roth V, Morand G, Mangin P, Uldin T.

Forensic Sci Int. 2013 Feb 10;225(1-3):53-9. doi: 10.1016/j.forsciint.2012.10.029. Epub 2012 Nov 13.

PMID:
23153800

Supplemental Content

Loading ...
Support Center